Not applicableEnded earlyNCT05471271What this trial is testingIL-2 PET Imaging in Advanced Solid TumoursWho this might be right forMetastatic Solid Tumor University Medical Center Groningen 1
Early research (Phase 1)Active Not RecruitingNCT05075993What this trial is testingStudy of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsWho this might be right forMetastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more M.D. Anderson Cancer Center 352
Early research (Phase 1)Study completedNCT00120939What this trial is testingStudy of Motexafin Gadolinium and Docetaxel for Advanced CancerWho this might be right forBreast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more Pharmacyclics LLC. 25
Early research (Phase 1)Study completedNCT05017012What this trial is testingEvaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)Who this might be right forAdvanced or Metastatic Solid Tumors Merck Sharp & Dohme LLC 142
Early research (Phase 1)Looking for participantsNCT05458219What this trial is testingA First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid TumorsWho this might be right forLocally Advanced Unresectable or Metastatic Solid Tumors Innovent Biologics (Suzhou) Co. Ltd. 470
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053What this trial is testingRare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)Who this might be right forRare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Early research (Phase 1)Looking for participantsNCT06493864What this trial is testingBL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsWho this might be right forBreast CancerSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 21
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT04467593What this trial is testingSafety Study of Whole Body Hyperthermia for Advanced CancerWho this might be right forAdvanced CancerPancreatic Cancer Metastatic ElmediX 16
Early research (Phase 1)Ended earlyNCT04167137What this trial is testingSafety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult ParticipantsWho this might be right forMetastatic Solid NeoplasmLymphoma Synlogic 32
Testing effectiveness (Phase 2)WithdrawnNCT04001101What this trial is testingAnti-PD-1 +/- RT for MSI-H Solid TumorsWho this might be right forMicrosatellite Instability HighMismatch Repair DeficiencyColorectal Cancer University of Colorado, Denver
Testing effectiveness (Phase 2)Looking for participantsNCT03556228What this trial is testingVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaWho this might be right forHead and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more VM Oncology, LLC 242
Testing effectiveness (Phase 2)Looking for participantsNCT06128551What this trial is testingStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma Revolution Medicines, Inc. 534
Early research (Phase 1)Active Not RecruitingNCT06088472What this trial is testingTIL Injection for the Treatment of Metastatic or Recurrent Solid TumorsWho this might be right forSolid Tumors, Adult Grit Biotechnology 12
Testing effectiveness (Phase 2)Ended earlyNCT01832857What this trial is testingPhase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer PatientsWho this might be right forCancer Cornerstone Pharmaceuticals 7
Not applicableLooking for participantsNCT04863612What this trial is testingSBRT in the Management of Solid Spinal MetastasesWho this might be right forExtradural TumorSpinal Metastases Universitaire Ziekenhuizen KU Leuven 100
Testing effectiveness (Phase 2)Study completedNCT02281409What this trial is testingSafety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Solid Tumors Memorial Sloan Kettering Cancer Center 17
Early research (Phase 1)Ended earlyNCT01159301What this trial is testingEntinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more National Cancer Institute (NCI) 44
Early research (Phase 1)Not Yet RecruitingNCT07827144What this trial is testingTest How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours)Who this might be right forSolid Tumours AIMEDBIO 90